ArticleBioengineering & translational medicine2018

Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.

Douglas R Vogus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.